Dr. Ying Chang is an Adjunct Professor of the Department of Chemical Engineering and Chair of Taiwan Science and Technology Hub at Stanford University. She is also a Research Fellow at the Genomics Research Center, Academia Sinica. Formerly, she was an Assistant Professor in the Department of Chemical Engineering and Materials Science, and the Department of Biomedical Engineering at the University of California-Irvine, Irvine, CA. Prior to her academic appointments, Dr. Chang had worked in various industrial R&D laboratories including as a Senior Engineer for the hard drive media at Maxmedia California, San Jose, CA (now Seagate), a Postdoctoral Scientist for the materials design of GeneChip at Affymetrix Corp, Santa Clara, CA (now Thermal Fisher Scientific). Her invention in single cell derived 3D organoid scaffold free culture system has led to Acrocyte Therapeutics, Inc. which she currently serves as the Chief Executive Officer. Highlights of her research include integrated nanomaterials, microfluidics, and bioreactors to control stem cell fates for tissue engineering and liquid biopsy for cancer diagnostics and precision medicine. Dr. Chang received her BS from National Taiwan University and PhD from Stanford University in Chemical Engineering.